Jeremie Sellam

Summary

Country: France

Publications

  1. ncbi request reprint Is osteoarthritis a metabolic disease?
    Jeremie Sellam
    Service de Rhumatologie, département hospitalo universitaire inflammation immunopathology biotherapy I2B, Universite Paris 6, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris, 184, rue du Faubourg Saint Antoine, 75012 Paris, France Electronic address
    Joint Bone Spine 80:568-73. 2013
  2. pmc Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study
    Fernando Kemta Lekpa
    Rheumatology Department, AP HP, Henri Mondor University Hospital, 51 avenue du Mal de Lattre de Tassigny, 94010 Creteil, France
    Arthritis Res Ther 14:R53. 2012
  3. ncbi request reprint [Osteoarthritis and obesity]
    Jeremie Sellam
    Service de Rhumatologie, Hopital Saint Antoine, AP HP, 75012 Paris
    Rev Prat 62:621-4. 2012
  4. ncbi request reprint B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study
    Jeremie Sellam
    Hopital Bicetre, Assistance Publique Hopitaux de Paris, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:933-8. 2011
  5. doi request reprint Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis
    Jeremie Sellam
    Hopital Bicetre, AP HP, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:3692-701. 2011
  6. pmc Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
    Jeremie Sellam
    Rhumatologie, Hopital Bicetre, Assistance Publique Hopitaux de Paris AP HP, INSERM U802, Universite Paris Sud 11, 78 rue du General Leclerc, 94270, Le Kremlin Bicetre, France
    Arthritis Res Ther 11:R156. 2009
  7. doi request reprint B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study
    Jeremie Sellam
    Hopital Bicetre, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    Arthritis Rheum 63:933-8. 2011
  8. pmc B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome
    Marc Ittah
    Rhumatologie, Institut Pour la Santé et la Recherche Médicale INSERM U 802, Hopital Bicetre, Assistance Publique Hopitaux de Paris AP HP, Universite Paris Sud 11, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre, France
    Arthritis Res Ther 8:R51. 2006
  9. doi request reprint CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis
    Jeremie Sellam
    Hopital Saint Antoine, AP HP, and Université Pierre et Marie Curie Paris 06, Paris, France
    Arthritis Rheum 65:2253-61. 2013
  10. pmc Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus
    Jeremie Sellam
    Service de Rhumatologie, Hopital de Bicetre, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre, France
    Ann Rheum Dis 66:790-7. 2007

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Is osteoarthritis a metabolic disease?
    Jeremie Sellam
    Service de Rhumatologie, département hospitalo universitaire inflammation immunopathology biotherapy I2B, Universite Paris 6, Hopital Saint Antoine, Assistance Publique Hopitaux de Paris, 184, rue du Faubourg Saint Antoine, 75012 Paris, France Electronic address
    Joint Bone Spine 80:568-73. 2013
    ..Thus, osteoarthritis is emerging as a disease that has a variety of phenotypes including a metabolic phenotype, in addition to the age-related and injury-related phenotypes. ..
  2. pmc Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? A multicentre retrospective observational study
    Fernando Kemta Lekpa
    Rheumatology Department, AP HP, Henri Mondor University Hospital, 51 avenue du Mal de Lattre de Tassigny, 94010 Creteil, France
    Arthritis Res Ther 14:R53. 2012
    ..The aim of this study was to evaluate, under real-life conditions, the safety and efficacy of tocilizumab in patients having failed anti-TNFα therapy for spondyloarthritis...
  3. ncbi request reprint [Osteoarthritis and obesity]
    Jeremie Sellam
    Service de Rhumatologie, Hopital Saint Antoine, AP HP, 75012 Paris
    Rev Prat 62:621-4. 2012
    ..Weight loss strategies remain a valuable therapeutic approach to prevent OA and reduce its symptoms, and must be associated with physical activity to allow for optimal outcomes...
  4. ncbi request reprint B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study
    Jeremie Sellam
    Hopital Bicetre, Assistance Publique Hopitaux de Paris, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:933-8. 2011
    ..To examine whether serum B cell markers can predict response to rituximab, a B cell-depleting monoclonal antibody, in patients with refractory rheumatoid arthritis (RA)...
  5. doi request reprint Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis
    Jeremie Sellam
    Hopital Bicetre, AP HP, INSERM U1012, and Université Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Rheum 63:3692-701. 2011
    ..To examine blood B cell subsets in patients with rheumatoid arthritis (RA) prior to B cell depletion therapy and to assess their potential as predictors of clinical response to rituximab (RTX)...
  6. pmc Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
    Jeremie Sellam
    Rhumatologie, Hopital Bicetre, Assistance Publique Hopitaux de Paris AP HP, INSERM U802, Universite Paris Sud 11, 78 rue du General Leclerc, 94270, Le Kremlin Bicetre, France
    Arthritis Res Ther 11:R156. 2009
    ....
  7. doi request reprint B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study
    Jeremie Sellam
    Hopital Bicetre, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    Arthritis Rheum 63:933-8. 2011
    ..To examine whether serum B cell markers can predict response to rituximab, a B cell-depleting monoclonal antibody, in patients with refractory rheumatoid arthritis (RA)...
  8. pmc B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome
    Marc Ittah
    Rhumatologie, Institut Pour la Santé et la Recherche Médicale INSERM U 802, Hopital Bicetre, Assistance Publique Hopitaux de Paris AP HP, Universite Paris Sud 11, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre, France
    Arthritis Res Ther 8:R51. 2006
    ..Our results suggest that an anti-BAFF therapeutic approach could be particularly interesting in pSS...
  9. doi request reprint CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis
    Jeremie Sellam
    Hopital Saint Antoine, AP HP, and Université Pierre et Marie Curie Paris 06, Paris, France
    Arthritis Rheum 65:2253-61. 2013
    ....
  10. pmc Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus
    Jeremie Sellam
    Service de Rhumatologie, Hopital de Bicetre, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre, France
    Ann Rheum Dis 66:790-7. 2007
    ..To analyse B cell activating factor (BAFF) receptor (BAFF-R) expression on peripheral lymphocytes from patients with primary Sjögren's syndrome (pSS) and systemic lupus erythematosus (SLE)...
  11. ncbi request reprint Failure to confirm coxsackievirus infection in primary Sjögren's syndrome
    Jacques Eric Gottenberg
    Hopital de Bicetre, Assistance Publique Hopitaux de Paris, Le Kremlin Bicetre, France
    Arthritis Rheum 54:2026-8. 2006
  12. pmc Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies
    Corinne Miceli-Richard
    Rhumatologie, Hopital Bicetre, Assistance Publique Hopitaux de Paris, 94275 Le Kremlin Bicetre, France
    Arthritis Res Ther 11:R77. 2009
    ..We investigated the EBV load and EBV-specific T-cell response in patients treated with methotrexate (MTX) or anti-TNF therapy...
  13. doi request reprint B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation
    Marc Ittah
    Rhumatologie, Institut Pour la Santé et la Recherche Médicale, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Universite Paris Sud 11, Le Kremlin Bicetre, France
    Eur J Immunol 39:1271-9. 2009
    ..Thus, PKR is the dsRNA sensor implicated in BAFF induction in SGEC after dsRNA stimulation. In autoimmune diseases, PKR may be an interesting target for preventing BAFF following the induction of innate immunity...
  14. pmc Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
    Frédéric Lavie
    Rheumatology Department, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Institut Pour la Santé et la Recherche Médicale INSERM U802, Universite Paris Sud 11, Le Kremlin Bicetre, France
    Ann Rheum Dis 66:700-3. 2007
    ..The cytokine B cell-activating factor of the TNF family (BAFF) is involved in the pathogenesis of autoimmune diseases...
  15. ncbi request reprint Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial
    Jeremie Sellam
    Hopital Saint Antoine, AP HP, DHU i2B, and Université Pierre et Marie Curie Paris 6, Paris, France
    Arthritis Rheumatol 66:2015-25. 2014
    ....
  16. doi request reprint Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
    Marc Ittah
    Rhumatologie, Institut Pour la Santé et la Recherche Médicale INSERM U 802, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Universite Paris Sud 11, Le Kremlin Bicetre, France
    Eur J Immunol 38:1058-64. 2008
    ..BAFF induction by target organs of autoimmune diseases after viral infection may be a link between innate immunity and autoimmunity...
  17. ncbi request reprint Autoantibody induction in patients with refractory spondyloarthropathy treated with infliximab and methotrexate
    Jeremie Sellam
    Rheumatology Department A, Paris V University, Cochin Teaching Hospital, AP HP, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Joint Bone Spine 72:48-52. 2005
    ..We investigated antibody induction in patients with spondyloarthropathy treated with both infliximab and methotrexate...
  18. pmc Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy
    Jeremie Sellam
    Service de Rhumatologie, Hopital de Bicetre, 78 rue du General Leclerc, 94275 Le Kremlin Bicetre, France
    Ann Rheum Dis 66:1610-5. 2007
    ..We aimed to investigate in vitro blood assays with TB-specific antigens (CFP-10, ESAT-6), in immune-mediated inflammatory diseases (IMID) for LTBI screening...
  19. doi request reprint Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients
    Benjamin Terrier
    Department of Internal Medicine, Groupe Hospitalier Pitie Salpetriere, Assistance Publique Hopitaux de Paris AP HP, CNRS UMR 7211, and Université Pierre et Marie Curie Paris 6, Paris, France
    Arthritis Rheum 60:2531-40. 2009
    ..To report on the long-term followup of a cohort of patients with hepatitis C virus (HCV)-related vasculitis treated with rituximab with or without PEGylated interferon alfa-2b (PEG-IFN alfa-2b) plus ribavirin...
  20. doi request reprint Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis
    Maxime Dougados
    Medicine Faculty, Rheumatology B Department, Descartes University UPRES EA 4058 APHP, Cochin Hospital, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 69:828-33. 2010
    ..To evaluate different global ultrasonographic (US) synovitis scoring systems as potential outcome measures of rheumatoid arthritis (RA) according to the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) filter...
  21. ncbi request reprint Fibroblastic rheumatism: Immunosuppressive therapy is not always required
    Alice Courties
    Service de Rhumatologie, université Paris 06, Hopital Saint Antoine, AP HP, DHU inflammation, Immunopathologie, biothérapie I2B, Paris, France
    Joint Bone Spine 81:178-9. 2014
    ..Such a case illustrates that improvement may be spontaneous and that non pharmacological approach is a cornerstone in the management of this disease. ..
  22. pmc No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome
    Jacques Eric Gottenberg
    Rhumatologie, INSERM E 109, Hopital Bicetre, Assistance Publique Hopitaux de Paris, Universite Paris Sud 11, Le Kremlin Bicetre, France
    Arthritis Res Ther 8:R30. 2006
    ..01), although no correlation was observed between BAFF polymorphism and mRNA level. In conclusion, BAFF gene polymorphism is neither involved in genetic predisposition to pSS nor associated with a specific pattern of antibody production...
  23. doi request reprint Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis
    Karine Chauffier
    Department of Rheumatology, Pierre and Marie Curie University Paris VI, Saint Antoine Hospital, AP HP, 184, rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France
    Rheumatology (Oxford) 51:60-8. 2012
    ..To assess the effect of biotherapies vs placebo on fatigue in two situations: inadequate response to conventional treatments (IR-DMARD) and inadequate response to anti-TNF (IR-anti-TNF) in RA...
  24. doi request reprint Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis
    Khadija Baccouche
    Department of Rheumatology, AP HP, Saint Antoine Hospital, Pierre et Marie Curie University, 184, rue du Faubourg Saint Antoine, 75012 Paris, France
    Joint Bone Spine 78:402-4. 2011
    ..We report herein a case of crusted scabies in a woman with severe rheumatoid arthritis (RA) treated by tocilizumab (TCZ), a monoclonal antibody blocking the interleukin-6 receptor...
  25. ncbi request reprint Use of infliximab to treat psoriatic arthritis in HIV-positive patients
    Jeremie Sellam
    Rheumatology Department, Saint Antoine Teaching Hospital, AP HP, Paris, France
    Joint Bone Spine 74:197-200. 2007
    ..Potential long-term effects such as opportunistic infections, malignancies, and loss of HIV control need to be evaluated...
  26. doi request reprint Is sarcoma a complication of arterial femoro-popliteal bypass?
    Gaëtane Nocturne
    Department of Rheumatology, Saint Antoine Hospital, AP HP, 75012 Paris, France
    Joint Bone Spine 77:358-60. 2010
    ..Chronic fibrosis secondary to the thrombosis could play a role in the tumorogenesis of this uncommon tumor. This case illustrates that sarcoma may be a late complication of vascular bypass and may have a rheumatologic presentation...